Semaglutide lowers risks for 10 cancers [Journal American Medical Assoc.]
- Jul 9, 2024
- 1 min read
Updated: Mar 8, 2025
Great news coming out of JAMA on July 5th that I wanted to share with you all.
GLP-1 drugs like the Semaglutide we offer here at our clinic - lowers the risk of developing 10 out of 13 obesity-associated cancers! This was done across a study of over 1.6 MILLION patients
The study was led by researchers at Case Western Reserve University school of Medicine and found that there was up to a 65% lower risk of different cancers that people who are overweight face. This is huge news!
The full article on this is here: https://arstechnica.com/science/2024/07/new-weight-loss-and-diabetes-drugs-linked-to-lower-risk-of-10-cancers/
The JAMA deep and nerdy research report is here: Glucagon-Like Peptide 1 Receptor Agonists and 13 Obesity-Associated Cancers in Patients With Type 2 Diabetes | Oncology | JAMA Network Open | JAMA Network
And don't forget you can start your own weight loss journey and reap the many benefits being found with GLP-1's by calling us at the number below or booking a free consult.
Pacific Northwest Medical Group
6622 112th ST E, Puyallup WA 98373
253-340-2270
Book a FREE consult now <- Click There!
